Unknown

Dataset Information

0

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.


ABSTRACT: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant quickly rose to dominance in mid-2021, displacing other variants, including Alpha. Studies using data from the United Kingdom and India estimated that Delta was 40-80% more transmissible than Alpha, allowing Delta to become the globally dominant variant. However, it was unclear if the ostensible difference in relative transmissibility was due mostly to innate properties of Delta's infectiousness or differences in the study populations. To investigate, we formed a partnership with SARS-CoV-2 genomic surveillance programs from all six New England US states. By comparing logistic growth rates, we found that Delta emerged 37-163% faster than Alpha in early 2021 (37% Massachusetts, 75% New Hampshire, 95% Maine, 98% Rhode Island, 151% Connecticut, and 163% Vermont). We next computed variant-specific effective reproductive numbers and estimated that Delta was 58-120% more transmissible than Alpha across New England (58% New Hampshire, 68% Massachusetts, 76% Connecticut, 85% Rhode Island, 98% Maine, and 120% Vermont). Finally, using RT-PCR data, we estimated that Delta infections generate on average ∼6 times more viral RNA copies per mL than Alpha infections. Overall, our evidence indicates that Delta's enhanced transmissibility could be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on the underlying immunity and behavior of distinct populations.

SUBMITTER: Earnest R 

PROVIDER: S-EPMC8509091 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.

Earnest Rebecca R   Uddin Rockib R   Matluk Nicholas N   Renzette Nicholas N   Siddle Katherine J KJ   Loreth Christine C   Adams Gordon G   Tomkins-Tinch Christopher H CH   Petrone Mary E ME   Rothman Jessica E JE   Breban Mallery I MI   Koch Robert Tobias RT   Billig Kendall K   Fauver Joseph R JR   Vogels Chantal B F CBF   Turbett Sarah S   Bilguvar Kaya K   De Kumar Bony B   Landry Marie L ML   Peaper David R DR   Kelly Kevin K   Omerza Greg G   Grieser Heather H   Meak Sim S   Martha John J   Dewey Hannah H HH   Kales Susan S   Berenzy Daniel D   Carpenter-Azevedo Kristin K   King Ewa E   Huard Richard C RC   Smole Sandra C SC   Brown Catherine M CM   Fink Timelia T   Lang Andrew S AS   Gallagher Glen R GR   Sabeti Pardis C PC   Gabriel Stacey S   MacInnis Bronwyn L BL   Tewhey Ryan R   Adams Mark D MD   Park Daniel J DJ   Lemieux Jacob E JE   Grubaugh Nathan D ND  

medRxiv : the preprint server for health sciences 20211007


The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant quickly rose to dominance in mid-2021, displacing other variants, including Alpha. Studies using data from the United Kingdom and India estimated that Delta was 40-80% more transmissible than Alpha, allowing Delta to become the globally dominant variant. However, it was unclear if the ostensible difference in relative transmissibility was due mostly to innate properties of Delta's infectiousness or differences in the  ...[more]

Similar Datasets

| S-EPMC8913280 | biostudies-literature
| S-EPMC9026126 | biostudies-literature
| S-EPMC9514330 | biostudies-literature
| EMPIAR-11070 | biostudies-other
| S-EPMC10352350 | biostudies-literature
| S-EPMC8431609 | biostudies-literature
| S-EPMC11680180 | biostudies-literature
| S-EPMC9095641 | biostudies-literature
| S-EPMC10125873 | biostudies-literature
| S-EPMC9509793 | biostudies-literature